Literature DB >> 25468841

A new future for hip fracture care--orthogeriatrician lead in an 'Acute' Hip Unit.

Abhaya Gupta1, William Havelock.   

Abstract

Although surgery is the definitive treatment for almost all hip fractures, there is evidence that outcomes such as morbidity and mortality are not determined by the type of surgery but by comorbidities and postoperative complications. A team approach, especially the involvement of an orthogeriatrician in managing medical issues, has been shown to improve surgical outcomes and should be encouraged in hospitals worldwide. An Acute Hip Unit is able to address the complex challenging needs of a frail older high-risk population soon after admission, therefore minimising delays. An orthogeriatrician-led unit can deal with the preoperative and complex postoperative medical, social, ethical, physical, and mental health issues that are associated with 'hip fracture syndrome', providing structured standardised evidence-based care by trained staff. This could be the model of care for the future.
© 2014 Royal College of Physicians.

Entities:  

Keywords:  Acute Hip Unit; hip fracture; orthogeriatrician

Mesh:

Year:  2014        PMID: 25468841      PMCID: PMC4954128          DOI: 10.7861/clinmedicine.14-6-591

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  2 in total

1.  The increase of osteopontin and β-carboxy-terminal cross-linking telopeptide of type I collagen enhances the risk of hip fracture in the elderly.

Authors:  Jian-Chun Lin; Zhong-Guo Liu; Rui-Ren Liu; Liang-Wen Xie; Huang-Lin Xie; He-Guo Cai
Journal:  J Clin Lab Anal       Date:  2020-05-14       Impact factor: 2.352

2.  PERFECTED enhanced recovery pathway (PERFECT-ER) versus standard acute hospital care for people after hip fracture surgery who have cognitive impairment: a feasibility cluster randomised controlled trial.

Authors:  Jane L Cross; Simon P Hammond; Lee Shepstone; Fiona Poland; Catherine Henderson; Tamara Backhouse; Bridget Penhale; Simon Donell; Martin Knapp; Douglas Lewins; Alasdair MacLullich; Martyn Patel; Opinder Sahota; Toby O Smith; Justin Waring; Robert Howard; Clive Ballard; Chris Fox
Journal:  BMJ Open       Date:  2022-02-28       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.